Company Rankings
• By
Other top 20 players also moved up in the rankings fired by double-digit growth. Lilly, Novo Nordisk and Amgen all gained on the Scrip 100, which is based on FY 2024 pharmaceutical sales.
Other top 20 players also moved up in the rankings fired by double-digit growth. Lilly, Novo Nordisk and Amgen all gained on the Scrip 100, which is based on FY 2024 pharmaceutical sales.